«El Confidencial»: Idea Therapeutics announces AGAcell®: An allogeneic cell therapy program in preclinical development for alopecia.
Idea Therapeutics announces AGAcell®: an allogeneic cell therapy program in preclinical development for alopecia. Idea Therapeutics closes €2.3 million seed round to advance the development of advanced therapy medicinal products with an open science and high clinical impact approach. AGAcell® is a preclinical research program that explores the use of allogeneic mesenchymal stem cells for […]
AGAcell® on «National Geographic»: Spanish researchers make a groundbreaking advance in the fight against alopecia
Spanish researchers make a groundbreaking advance in the fight against alopecia. They have applied a combined treatment of cell therapy and an energizing molecule—marking the first such treatment of its kind to be published worldwide. Clinical trials in humans are expected to begin soon. From the moment a fetus begins to form, the first genetic […]
Idea TX on «Expansión»: Idea TX secures €2.3 million in funding to address alopecia through stem cell-based therapy.
Biotech firm Idea TX raises €2.3 million to combat alopecia using stem cell therapy The biotech company Idea Therapeutics has closed a €2.3 million seed funding round, supported by private investors and the Centre for the Development of Industrial Technology and Innovation (CDTI), within the framework of the Perte (Strategic Projects for Economic Recovery and […]
AGAcell® on «La Sexta»: Idea Therapeutics’ Bet on Androgenetic Alopecia
Don’t miss the report aired by La Sexta on AGAcell®, the cell therapy research program from Idea Tx, led by Principal Investigator Dr. Eduardo López Bran, in collaboration with Hospital Clínico San Carlos, focused on the treatment of androgenetic alopecia. In the report, Dr. López Bran outlines the progress made in this promising line of research, based […]